glp 1 shopping Grocery shifts as weight loss drugs change diets How GLP-1 Medications Are Reshaping
Description
Results: Fifty-one studies met inclusion criteria
Both represent $50 reductions from current prices for doses it sells directly to patients
Among the 3,532 participants in the FLOW trial, 19.2% (678 individuals) had heart failure at baseline, with 47.9% classified as having HFpEF, 18.1% as having heart failure with reduced ejection fraction (HFrEF), and 33.9% with unknown status
Evaluation of out-of-pocket costs and treatment intensification with an SGLT2 inhibitor or GLP-1 RA in patients with type 2 diabetes and cardiovascular disease
doi: 10.5858/133.3.365
